Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 303

1.

Diagnostic value of biopsy sampling in predicting histology in patients with diffuse malignant pleural mesothelioma.

Chirieac LR, Hung YP, Foo WC, Hofer MD, VanderLaan PA, Richards WG, Sugarbaker DJ, Bueno R.

Cancer. 2019 Aug 7. doi: 10.1002/cncr.32416. [Epub ahead of print]

PMID:
31390057
2.

A Proposed System Toward Standardizing Surgical-Based Treatments for Malignant Pleural Mesothelioma, From the Joint National Cancer Institute-International Association for the Study of Lung Cancer-Mesothelioma Applied Research Foundation Taskforce.

Friedberg JS, Culligan MJ, Tsao AS, Rusch V, Sepesi B, Pass HI, Bueno R, Burt B, Sugarbaker DJ, de Perrot M, Adjei AA, Adusumilli PS, Hirsch FR, Malik SM, Harpole DJ Jr.

J Thorac Oncol. 2019 Aug;14(8):1343-1353. doi: 10.1016/j.jtho.2019.04.029. Epub 2019 May 25. Review.

PMID:
31136816
3.

Prognostic value of neoadjuvant treatment response in locally advanced esophageal adenocarcinoma.

Groth SS, Burt BM, Farjah F, Smaglo BG, Sada YH, Sugarbaker DJ, Massarweh NN.

J Thorac Cardiovasc Surg. 2019 Apr;157(4):1682-1693.e1. doi: 10.1016/j.jtcvs.2018.11.131. Epub 2018 Dec 15.

PMID:
30711279
4.

Povidone-iodine results in rapid killing of thymic epithelial tumour cells through cellular fixation†.

Lee HS, Jang HJ, Lo EM, Truong CY, Groth SS, Friedberg JS, Sugarbaker DJ, Burt BM.

Interact Cardiovasc Thorac Surg. 2019 Mar 1;28(3):353-359. doi: 10.1093/icvts/ivy248.

5.

A Phase I Trial of Surgical Resection and Intraoperative Hyperthermic Cisplatin and Gemcitabine for Pleural Mesothelioma.

Burt BM, Richards WG, Lee HS, Bartel S, Dasilva MC, Gill RR, Jaklitsch MT, Johnson BE, Swanson SJ, Bueno R, Sugarbaker DJ.

J Thorac Oncol. 2018 Sep;13(9):1400-1409. doi: 10.1016/j.jtho.2018.04.032. Epub 2018 May 9.

6.

Comprehensive immunoproteogenomic analyses of malignant pleural mesothelioma.

Lee HS, Jang HJ, Choi JM, Zhang J, de Rosen VL, Wheeler TM, Lee JS, Tu T, Jindra PT, Kerman RH, Jung SY, Kheradmand F, Sugarbaker DJ, Burt BM.

JCI Insight. 2018 Apr 5;3(7). pii: 98575. doi: 10.1172/jci.insight.98575. eCollection 2018 Apr 5.

7.

Therapeutic R2 resection for pleural mesothelioma.

Nguyen D, Sugarbaker DJ, Burt BM.

J Thorac Cardiovasc Surg. 2018 Jun;155(6):2734-2735. doi: 10.1016/j.jtcvs.2018.01.025. Epub 2018 Feb 1. No abstract available.

PMID:
29477257
8.

Matrix metalloproteinase 12 promotes tumor propagation in the lung.

Ella E, Harel Y, Abraham M, Wald H, Benny O, Karsch-Bluman A, Vincent D, Laurent D, Amir G, Izhar U, Shapira OM, Yoon D, Lee HS, Sugarbaker DJ, Burt B, Peled A, Wald O.

J Thorac Cardiovasc Surg. 2018 May;155(5):2164-2175.e1. doi: 10.1016/j.jtcvs.2017.11.110. Epub 2018 Feb 21. Erratum in: J Thorac Cardiovasc Surg. 2019 Sep;158(3):966.

PMID:
29429629
9.

Postoperative Chylothorax After Thoracoabdominal Aortic Aneurysm Repair.

Wu D, Chesnokova AE, Akvan S, Price MD, Sugarbaker DJ, Coselli JS, LeMaire SA.

Semin Thorac Cardiovasc Surg. 2018 Summer;30(2):215-219. doi: 10.1053/j.semtcvs.2018.02.005. Epub 2018 Feb 8.

PMID:
29428620
10.

New Concepts in the Treatment of Malignant Pleural Mesothelioma.

Wald O, Sugarbaker DJ.

Annu Rev Med. 2018 Jan 29;69:365-377. doi: 10.1146/annurev-med-041316-085813. Epub 2017 Oct 13. Review.

PMID:
29029582
11.

Soluble Mesothelin-Related Peptides to Monitor Recurrence After Resection of Pleural Mesothelioma.

Burt BM, Lee HS, Lenge De Rosen V, Hamaji M, Groth SS, Wheeler TM, Sugarbaker DJ.

Ann Thorac Surg. 2017 Nov;104(5):1679-1687. doi: 10.1016/j.athoracsur.2017.06.042. Epub 2017 Sep 28.

PMID:
28964420
12.

Intraoperative adjuncts for malignant pleural mesothelioma.

Chan WH, Sugarbaker DJ, Burt BM.

Transl Lung Cancer Res. 2017 Jun;6(3):285-294. doi: 10.21037/tlcr.2017.05.04. Review.

13.

Malignant pleural mesothelioma: key determinants in tailoring the right treatment for the right patient.

Wald O, Sugarbaker DJ.

J Thorac Dis. 2017 Mar;9(3):485-489. doi: 10.21037/jtd.2017.03.27. No abstract available.

14.

Alternative conduits for esophageal replacement.

Bakshi A, Sugarbaker DJ, Burt BM.

Ann Cardiothorac Surg. 2017 Mar;6(2):137-143. doi: 10.21037/acs.2017.03.07.

15.

Genomic Analysis of Thymic Epithelial Tumors Identifies Novel Subtypes Associated with Distinct Clinical Features.

Lee HS, Jang HJ, Shah R, Yoon D, Hamaji M, Wald O, Lee JS, Sugarbaker DJ, Burt BM.

Clin Cancer Res. 2017 Aug 15;23(16):4855-4864. doi: 10.1158/1078-0432.CCR-17-0066. Epub 2017 Apr 11.

16.

The seven attributes of the academic surgeon: Critical aspects of the archetype and contributions to the surgical community.

Rosengart TK, Mason MC, LeMaire SA, Brandt ML, Coselli JS, Curley SA, Mattox KL, Mills JL, Sugarbaker DJ, Berger DA.

Am J Surg. 2017 Aug;214(2):165-179. doi: 10.1016/j.amjsurg.2017.02.003. Epub 2017 Feb 20.

17.

Integrated genomic analysis of recurrence-associated small non-coding RNAs in oesophageal cancer.

Jang HJ, Lee HS, Burt BM, Lee GK, Yoon KA, Park YY, Sohn BH, Kim SB, Kim MS, Lee JM, Joo J, Kim SC, Yun JS, Na KJ, Choi YL, Park JL, Kim SY, Lee YS, Han L, Liang H, Mak D, Burks JK, Zo JI, Sugarbaker DJ, Shim YM, Lee JS.

Gut. 2017 Feb;66(2):215-225. doi: 10.1136/gutjnl-2015-311238. Epub 2016 Aug 9.

18.

Utility of Adjuvant Chemotherapy After Neoadjuvant Chemoradiation and Esophagectomy for Esophageal Cancer.

Burt BM, Groth SS, Sada YH, Farjah F, Cornwell L, Sugarbaker DJ, Massarweh NN.

Ann Surg. 2017 Aug;266(2):297-304. doi: 10.1097/SLA.0000000000001954.

PMID:
27501170
19.

Progression of EGFR-Mutant Lung Adenocarcinoma is Driven By Alveolar Macrophages.

Wang DH, Lee HS, Yoon D, Berry G, Wheeler TM, Sugarbaker DJ, Kheradmand F, Engleman E, Burt BM.

Clin Cancer Res. 2017 Feb 1;23(3):778-788. doi: 10.1158/1078-0432.CCR-15-2597. Epub 2016 Aug 5.

20.

Role of thoracoscopy, mediastinoscopy and laparoscopy in the diagnosis and staging of malignant pleural mesothelioma.

Wald O, Groth SS, Burt BM, Sugarbaker DJ.

J Vis Surg. 2016 Aug 2;2:129. doi: 10.21037/jovs.2016.07.12. eCollection 2016. Review.

21.

Pneumonectomy for Non-Small Cell Lung Cancer.

Sugarbaker DJ, Haywood-Watson RJ, Wald O.

Surg Oncol Clin N Am. 2016 Jul;25(3):533-51. doi: 10.1016/j.soc.2016.02.012. Review.

PMID:
27261914
22.

Perioperative Ischemic Optic Neuropathy Following Extrapleural Pneumonectomy.

Ng JM, Sugarbaker DJ, Bienfang DC, Richards WG, DaSilva MC, Frendl G, Hartigan PM.

J Cardiothorac Vasc Anesth. 2016 Dec;30(6):1645-1648. doi: 10.1053/j.jvca.2016.01.002. Epub 2016 Jan 7. No abstract available.

PMID:
27178100
23.

Perspective on malignant pleural mesothelioma diagnosis and treatment.

Wald O, Sugarbaker DJ.

Ann Transl Med. 2016 Mar;4(6):120. doi: 10.21037/atm.2016.03.17. No abstract available.

24.

Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations.

Bueno R, Stawiski EW, Goldstein LD, Durinck S, De Rienzo A, Modrusan Z, Gnad F, Nguyen TT, Jaiswal BS, Chirieac LR, Sciaranghella D, Dao N, Gustafson CE, Munir KJ, Hackney JA, Chaudhuri A, Gupta R, Guillory J, Toy K, Ha C, Chen YJ, Stinson J, Chaudhuri S, Zhang N, Wu TD, Sugarbaker DJ, de Sauvage FJ, Richards WG, Seshagiri S.

Nat Genet. 2016 Apr;48(4):407-16. doi: 10.1038/ng.3520. Epub 2016 Feb 29.

PMID:
26928227
25.

Detection of Occult Micrometastases in Patients With Clinical Stage I Non-Small-Cell Lung Cancer: A Prospective Analysis of Mature Results of CALGB 9761 (Alliance).

Martin LW, D'Cunha J, Wang X, Herzan D, Gu L, Abraham N, Demmy TL, Detterbeck FC, Groth SS, Harpole DH, Krasna MJ, Kernstine K, Kohman LJ, Patterson GA, Sugarbaker DJ, Vollmer RT, Maddaus MA, Kratzke RA.

J Clin Oncol. 2016 May 1;34(13):1484-91. doi: 10.1200/JCO.2015.63.4543. Epub 2016 Feb 29.

26.

The American Association for Thoracic Surgery Consensus Guidelines: Reasons and purpose.

Svensson LG, Gillinov AM, Weisel RD, Keshavjee S, Bacha EA, Moon MR, Cameron DE, Sugarbaker DJ, Adams DH, Gaynor JW, Coselli JS, Del Nido PJ, Jones D, Sundt TM, Cohn LH, Pomar JL, Lytle BW, Schaff HV.

J Thorac Cardiovasc Surg. 2016 Apr;151(4):935-9.e1. doi: 10.1016/j.jtcvs.2015.09.138. Epub 2016 Jan 23. Review.

27.

Gender-Specific Molecular and Clinical Features Underlie Malignant Pleural Mesothelioma.

De Rienzo A, Archer MA, Yeap BY, Dao N, Sciaranghella D, Sideris AC, Zheng Y, Holman AG, Wang YE, Dal Cin PS, Fletcher JA, Rubio R, Croft L, Quackenbush J, Sugarbaker PE, Munir KJ, Battilana JR, Gustafson CE, Chirieac LR, Ching SM, Wong J, Tay LC, Rudd S, Hercus R, Sugarbaker DJ, Richards WG, Bueno R.

Cancer Res. 2016 Jan 15;76(2):319-28. doi: 10.1158/0008-5472.CAN-15-0751. Epub 2015 Nov 10.

28.

Surgery versus SABR for resectable non-small-cell lung cancer.

Hamaji M, Groth SS, Sugarbaker DJ, Burt BM.

Lancet Oncol. 2015 Aug;16(8):e372. doi: 10.1016/S1470-2045(15)00091-1. No abstract available.

PMID:
26248839
29.

Management of Complications After Pneumonectomy.

Groth SS, Burt BM, Sugarbaker DJ.

Thorac Surg Clin. 2015 Aug;25(3):335-48. doi: 10.1016/j.thorsurg.2015.04.006. Epub 2015 Jun 12. Review.

PMID:
26210929
30.

Updated patterns of failure after multimodality therapy for malignant pleural mesothelioma.

Baldini EH, Richards WG, Gill RR, Goodman BM, Winfrey OK, Eisen HM, Mak RH, Chen AB, Kozono DE, Bueno R, Sugarbaker DJ.

J Thorac Cardiovasc Surg. 2015 May;149(5):1374-81. doi: 10.1016/j.jtcvs.2014.10.128. Epub 2015 Feb 7.

31.

Minimally invasive esophagectomy: results of a prospective phase II multicenter trial-the eastern cooperative oncology group (E2202) study.

Luketich JD, Pennathur A, Franchetti Y, Catalano PJ, Swanson S, Sugarbaker DJ, De Hoyos A, Maddaus MA, Nguyen NT, Benson AB, Fernando HC.

Ann Surg. 2015 Apr;261(4):702-7. doi: 10.1097/SLA.0000000000000993.

32.

VATS lobectomy has better perioperative outcomes than open lobectomy: CALGB 31001, an ancillary analysis of CALGB 140202 (Alliance).

Nwogu CE, D'Cunha J, Pang H, Gu L, Wang X, Richards WG, Veit LJ, Demmy TL, Sugarbaker DJ, Kohman LJ, Swanson SJ; Alliance for Clinical Trials in Oncology.

Ann Thorac Surg. 2015 Feb;99(2):399-405. doi: 10.1016/j.athoracsur.2014.09.018. Epub 2014 Dec 10.

33.

Safety and efficacy of radiation dose delivered via iodine-125 brachytherapy mesh implantation for deep cavity sarcomas.

Fairweather M, Wang J, Devlin PM, Hansen J, Baldini EH, Ready JE, Sugarbaker DJ, Bertagnolli MM, Raut CP.

Ann Surg Oncol. 2015 May;22(5):1455-63. doi: 10.1245/s10434-014-4171-y. Epub 2014 Oct 24.

PMID:
25341749
34.
35.

Clarity of purpose, focused attention: The essence of excellence.

Sugarbaker DJ.

J Thorac Cardiovasc Surg. 2014 Sep;148(3):764-71. doi: 10.1016/j.jtcvs.2014.06.028. Epub 2014 Jun 26. No abstract available.

36.

Transhiatal esophagectomy after previous right pneumonectomy.

Velotta JB, Vasquez CR, Sugarbaker DJ.

J Thorac Cardiovasc Surg. 2014 Aug;148(2):e150-2. doi: 10.1016/j.jtcvs.2014.05.005. Epub 2014 May 6. No abstract available.

37.

Relationship between margin distance and local recurrence among patients undergoing wedge resection for small (≤2 cm) non-small cell lung cancer.

Mohiuddin K, Haneuse S, Sofer T, Gill R, Jaklitsch MT, Colson YL, Wee J, Bueno R, Mentzer SJ, Sugarbaker DJ, Swanson SJ.

J Thorac Cardiovasc Surg. 2014 Apr;147(4):1169-75; discussion 1175-7. doi: 10.1016/j.jtcvs.2013.11.056. Epub 2014 Jan 2.

38.

Gene expression ratio test distinguishes normal lung from lung tumors in solid tissue and FNA biopsies.

De Rienzo A, Yeap BY, Cibas ES, Richards WG, Dong L, Gill RR, Sugarbaker DJ, Bueno R.

J Mol Diagn. 2014 Mar;16(2):267-72. doi: 10.1016/j.jmoldx.2013.11.008. Epub 2014 Jan 9.

39.

Clinicopathologic characteristics of malignant mesotheliomas arising in patients with a history of radiation for Hodgkin and non-Hodgkin lymphoma.

Chirieac LR, Barletta JA, Yeap BY, Richards WG, Tilleman T, Bueno R, Baldini EH, Godleski J, Sugarbaker DJ.

J Clin Oncol. 2013 Dec 20;31(36):4544-9. doi: 10.1200/JCO.2013.49.9616. Epub 2013 Nov 18.

PMID:
24248693
40.

Clinical indications and results after chest wall resection for recurrent mesothelioma.

Burt BM, Ali SO, DaSilva MC, Yeap BY, Richards WG, Baldini EH, Sugarbaker DJ.

J Thorac Cardiovasc Surg. 2013 Dec;146(6):1373-9; discussion 1379-80. doi: 10.1016/j.jtcvs.2013.07.012. Epub 2013 Oct 8.

41.

Prospective phase II trial of preresection thoracoscopic mediastinal restaging after neoadjuvant therapy for IIIA (N2) non-small cell lung cancer: results of CALGB Protocol 39803.

Jaklitsch MT, Gu L, Demmy T, Harpole DH, D'Amico TA, McKenna RJ, Krasna MJ, Kohman LJ, Swanson SJ, DeCamp MM, Wang X, Barry S, Sugarbaker DJ; CALGB Thoracic Surgeons.

J Thorac Cardiovasc Surg. 2013 Jul;146(1):9-16. doi: 10.1016/j.jtcvs.2012.12.069.

42.

A microthymoma and no germinal centre in myasthenia gravis.

Hamaji M, Vanderlaan PA, Sugarbaker DJ, McNamee CJ.

Eur J Cardiothorac Surg. 2013 Dec;44(6):1146-7. doi: 10.1093/ejcts/ezt208. Epub 2013 Apr 15.

PMID:
23588037
43.

Hyperthermic intraoperative pleural cisplatin chemotherapy extends interval to recurrence and survival among low-risk patients with malignant pleural mesothelioma undergoing surgical macroscopic complete resection.

Sugarbaker DJ, Gill RR, Yeap BY, Wolf AS, DaSilva MC, Baldini EH, Bueno R, Richards WG.

J Thorac Cardiovasc Surg. 2013 Apr;145(4):955-963. doi: 10.1016/j.jtcvs.2012.12.037. Epub 2013 Feb 21.

44.

The role of surgical cytoreduction in the treatment of malignant pleural mesothelioma: meeting summary of the International Mesothelioma Interest Group Congress, September 11-14, 2012, Boston, Mass.

Rusch V, Baldini EH, Bueno R, De Perrot M, Flores R, Hasegawa S, Klepetko W, Krug L, Lang-Lazdunski L, Pass H, Weder W, Sugarbaker DJ; participants in the 2012 International Mesothelioma Interest Group Congress.

J Thorac Cardiovasc Surg. 2013 Apr;145(4):909-910. doi: 10.1016/j.jtcvs.2013.01.039. Epub 2013 Feb 14. No abstract available.

45.

Clinicopathologic indices can improve patient selection in malignant mesothelioma.

Sugarbaker DJ.

Oncology (Williston Park). 2012 Dec;26(12):1175-6. No abstract available.

46.

Postoperative antibacterial prophylaxis for the prevention of infectious complications associated with tube thoracostomy in patients undergoing elective general thoracic surgery: a double-blind, placebo-controlled, randomized trial.

Oxman DA, Issa NC, Marty FM, Patel A, Panizales CZ, Johnson NN, Licona JH, McKenna SS, Frendl G, Mentzer SJ, Jaklitsch MT, Bueno R, Colson Y, Swanson SJ, Sugarbaker DJ, Baden LR.

JAMA Surg. 2013 May;148(5):440-6. doi: 10.1001/jamasurg.2013.1372.

PMID:
23325435
47.

Vorinostat eliminates multicellular resistance of mesothelioma 3D spheroids via restoration of Noxa expression.

Barbone D, Cheung P, Battula S, Busacca S, Gray SG, Longley DB, Bueno R, Sugarbaker DJ, Fennell DA, Broaddus VC.

PLoS One. 2012;7(12):e52753. doi: 10.1371/journal.pone.0052753. Epub 2012 Dec 26.

48.

The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups.

Jaklitsch MT, Jacobson FL, Austin JH, Field JK, Jett JR, Keshavjee S, MacMahon H, Mulshine JL, Munden RF, Salgia R, Strauss GM, Swanson SJ, Travis WD, Sugarbaker DJ.

J Thorac Cardiovasc Surg. 2012 Jul;144(1):33-8. doi: 10.1016/j.jtcvs.2012.05.060.

49.

Development of The American Association for Thoracic Surgery guidelines for low-dose computed tomography scans to screen for lung cancer in North America: recommendations of The American Association for Thoracic Surgery Task Force for Lung Cancer Screening and Surveillance.

Jacobson FL, Austin JH, Field JK, Jett JR, Keshavjee S, MacMahon H, Mulshine JL, Munden RF, Salgia R, Strauss GM, Sugarbaker DJ, Swanson SJ, Travis WD, Jaklitsch MT.

J Thorac Cardiovasc Surg. 2012 Jul;144(1):25-32. doi: 10.1016/j.jtcvs.2012.05.059.

50.

Interatrial shunting after major thoracic surgery: a rare but clinically significant event.

Ng SY, Sugarbaker DJ, Frendl G.

Ann Thorac Surg. 2012 May;93(5):1647-51. doi: 10.1016/j.athoracsur.2012.02.029.

PMID:
22541195

Supplemental Content

Loading ...
Support Center